CHMP7 protein, partial (48-62)

Charged multivesicular body protein 7

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-129

Synonyms/Alias:CHMP7 protein, partial (48-62)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
GLATVLQDLLRRGEL
Areas of Interest
Antigen-presenting Cells; Cancer Research

CHMP7 protein, partial (48-62) is a synthetic peptide fragment corresponding to amino acids 48 through 62 of the human Charged Multivesicular Body Protein 7 (CHMP7). As a member of the ESCRT-III (Endosomal Sorting Complex Required for Transport III) family, CHMP7 plays a crucial role in membrane remodeling events, particularly those associated with endosomal trafficking and nuclear envelope reformation. The partial peptide sequence derived from this region is of significant interest for dissecting the structure-function relationships of CHMP7, enabling researchers to study its biochemical interactions, regulatory mechanisms, and involvement in cellular compartmentalization processes. Through its unique sequence and functional motifs, this peptide serves as a valuable tool for investigating the molecular underpinnings of ESCRT-mediated membrane dynamics.

Peptide mapping: Researchers employ the CHMP7 (48-62) fragment as a defined probe in peptide mapping studies to elucidate the structural domains critical for ESCRT-III assembly and function. By analyzing the binding affinities and conformational properties of this peptide, scientists can identify interactive surfaces and conserved motifs that contribute to the formation of higher-order ESCRT-III complexes. Such studies provide insights into the modular organization of CHMP7 and its interface with other ESCRT components, facilitating the rational design of experiments to modulate ESCRT activity in vitro.

Protein-protein interaction assays: The synthetic CHMP7 (48-62) peptide is frequently utilized in biochemical assays to characterize its interaction with binding partners, such as other ESCRT-III subunits or regulatory proteins. By incorporating this peptide into pull-down assays, surface plasmon resonance, or fluorescence-based binding studies, investigators can dissect the specificity and affinity of CHMP7-mediated interactions. These experiments are essential for delineating the molecular determinants governing ESCRT-III recruitment and assembly at membrane sites, advancing the understanding of intracellular trafficking pathways.

Antibody epitope mapping: The defined sequence of the CHMP7 (48-62) peptide makes it an ideal antigen for antibody production and epitope mapping studies. By using this fragment as an immunogen or as a target in screening assays, researchers can generate and validate antibodies that specifically recognize CHMP7 or its functional domains. Such antibodies are instrumental in downstream applications, including immunoblotting, immunofluorescence, and immunoprecipitation, where precise detection of CHMP7 is required for cellular and molecular analyses.

Structural biology: Incorporation of the CHMP7 (48-62) peptide into structural studies enables high-resolution characterization of its secondary and tertiary conformations. Techniques such as nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography can be applied to this defined fragment to reveal its folding patterns, flexibility, and potential for forming coiled-coil or helical structures. These insights contribute to the broader understanding of ESCRT-III architecture and the structural transitions that underpin membrane remodeling events.

Functional modulation studies: The CHMP7 (48-62) peptide serves as a tool for competitive inhibition or functional perturbation experiments in vitro. By introducing this fragment into reconstituted systems or cell-free assays, scientists can assess its capacity to interfere with full-length CHMP7 function or ESCRT-III complex assembly. Such studies are valuable for identifying regulatory checkpoints within the ESCRT pathway and for probing the mechanistic basis of membrane scission and nuclear envelope repair, supporting the development of novel experimental models in cell biology.

Source#
Homo sapiens (human)
Epitope
48-62
Restricting HLA
HLA-A2
References
Kwasi Antwi; Mol Immunol 2009

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicesCustom Conjugation ServicecGMP Peptide ServicePeptide CDMOPeptide Synthesis ServicesPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers